Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI)

Ge, Junbo; Li, Yanlin; Qian, Juying; Shi, Jing; Wang, Qibing; Niu, Yuhong; Fan, Bin Prof; Liu, Xuebo; Zhang, Shaoheng; Sun, Aijun; Zou, Yunzeng

doi:10.1136/hrt.2005.085431

Cited by 152 publications

(70 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Subgroup analysis suggested that the benefit was greatest in patients with the worst LVEF at baseline. In the study conducted by Ge et al, 7 the mean LVEF increased by about 5% in the BMC group (from 53.8%±9.2% at baseline to 58.6%±9.9% at follow-up, P<.05), while LVEF decreased in the control group (from 58.2%±7.5% at baseline to 56.3%±3.5% at follow-up). In the study conducted by Suárez de Lezo et al, 4 the average increase in the ejection fraction exceeded 20% following intracoronary BMC treatment, the largest improvement reported to date (baseline: 37%±5%, followup: 58%±920%), while a significantly smaller increase (6%, P = .003) was observed in the control group (baseline: 39%±6%, follow-up: 45%±8%).…”

Section: Lvef Change Noted In Individual Studiesmentioning

confidence: 86%

“…Suárez de Lezo et al 4 defined LV dysfunction as angiographic ejection fraction <45%. In the studies by Ge et al 7 and Chen et al, 10 LV dysfunction was not defined.…”

Section: Data Synthesis and Analysismentioning

confidence: 99%

“…The modalities used to evaluate change in global ejection fraction included magnetic resonance imaging (MRI), 6,8,9 LV angiography, 4,5 cardiac echocardiography, 6,7,10 and single photon emission computed tomography (SPECT). 6 We did not attempt to reclassify outcomes retrospectively, because such an attempt would not only be impractical, but would also create the potential for bias.…”

Section: Data Synthesis and Analysismentioning

confidence: 99%

“…Our search yielded 7 randomized controlled trials (Suárez de Lezo et al, 4 Schächinger et al, 5 Lunde et al, 6 Ge et al, 7 Janssens et al, 8 Wollert et al, 9 and Chen et al 10 ), evaluating changes in LVEF following intracoronary BMC therapy in relation to control groups. A meta-analysis of 516 patients (BMC group, 256; control group, 260) was performed (Table 1 and 2).…”

Section: Study Selectionmentioning

confidence: 99%

“…The variation in the LVEF could also be due to the fact that different modalities were used for the estimation of LVEF in the various trials included for meta-analysis: MRI, 6,8,9 LV angiography, 4,5 cardiac echocardiography, 6,7,10 and SPECT. 6 …”

Section: Limitationsmentioning

confidence: 99%

See 4 more Smart Citations

Stem Cells Improve Left Ventricular Function in Acute Myocardial Infarction

Singh

Arora

Handa

et al. 2009

Clinical Cardiology

View full text Add to dashboard Cite

BackgroundAnimal studies have suggested dramatic improvement in cardiac function after acute myocardial infarction (AMI) through regeneration of the myocardium or neovascularization by transfer of cells derived from bone marrow (BMC) generated clinical studies. Recently published small sized studies have yielded mixed results, leaving the question unanswered.HypothesisWe analyzed data from these studies in a meta‐analysis to investigate if intracoronary stem cell therapy was effective in improving cardiac function.MethodsA total of 7 randomized controlled trials meeting the inclusion criteria were identified by a systematic literature search. Primary endpoint was change in global left ventricular ejection fraction (LVEF) baseline to follow‐up (ranging between 3 to 6 months). The meta‐analysis consisted of 516 patients (BMC group, 256; control group, 260). A 2‐sided α error of less than .05 was considered to be statistically significant (P<.05).ResultsThere were no significant differences in patient characteristics between the BMC treatment and control groups at baseline. Compared to the control group, patients in the BMC treatment group had significantly greater increase in LVEF from baseline to follow‐up (mean difference: 6.108%; SE: 1.753%; 95% confidence interval [CI]: 2.672%− 9.543%; P<.001).ConclusionsThe present meta‐analysis suggests that intracoronary bone marrow stem cell infusion may be effective in improving left ventricular systolic function in patients after acute myocardial infarction. Copyright © 2009 Wiley Periodicals, Inc.

show abstract

Section: Lvef Change Noted In Individual Studiesmentioning

confidence: 86%

“…Suárez de Lezo et al 4 defined LV dysfunction as angiographic ejection fraction <45%. In the studies by Ge et al 7 and Chen et al, 10 LV dysfunction was not defined.…”

Section: Data Synthesis and Analysismentioning

confidence: 99%

Section: Data Synthesis and Analysismentioning

confidence: 99%

Section: Study Selectionmentioning

confidence: 99%

Section: Limitationsmentioning

confidence: 99%

See 3 more Smart Citations

Stem Cells Improve Left Ventricular Function in Acute Myocardial Infarction

Singh

Arora

Handa

et al. 2009

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

Adult Bone Marrow–Derived Cells for Cardiac Repair

et al. 2007

View full text Add to dashboard Cite

Background:The results from small clinical studies suggest that therapy with adult bone marrow (BM)derived cells (BMCs) reduces infarct size and improves left ventricular function and perfusion. However, the effects of BMC transplantation in patients with ischemic heart disease remains unclear.Methods: We searched MEDLINE, EMBASE, Science Citation Index, CINAHL (Cumulative Index to Nursing and Allied Health), and the Cochrane Central Register of Controlled Trials (CENTRAL) (through July 2006) for randomized controlled trials and cohort studies of BMC transplantation to treat ischemic heart disease. We conducted a random-effects meta-analysis across eligible studies measuring the same outcomes.Results: Eighteen studies (N = 999 patients) were eligible. The adult BMCs included BM mononuclear cells, BM mesenchymal stem cells, and BM-derived circulat-ing progenitor cells. Compared with controls, BMC transplantation improved left ventricular ejection fraction (pooled difference, 3.66%; 95% confidence interval [CI], 1.93% to 5.40%; PϽ.001); reduced infarct scar size (−5.49%; 95% CI, −9.10% to −1.88%; P=.003); and reduced left ventricular end-systolic volume (−4.80 mL; 95% CI, −8.20 to −1.41 mL; P=.006). Conclusions:The available evidence suggests that BMC transplantation is associated with modest improvements in physiologic and anatomic parameters in patients with both acute myocardial infarction and chronic ischemic heart disease, above and beyond conventional therapy. Therapy with BMCs seems safe. These results support conducting large randomized trials to evaluate the impact of BMC therapy vs the standard of care on patient-important outcomes.

show abstract